Eli Lilly (LLY) Interest & Investment Income (2009 - 2012)

Eli Lilly has reported Interest & Investment Income for 4 years, with the latest figure at $26.1 million in Q1 2012.

• For the quarter ending Q1 2012, Interest & Investment Income rose 68.39% year-over-year to $26.1 million; the trailing twelve-month figure through Mar 2012 stood at $90.5 million (up 59.33% YoY), and the FY2011 full-year result was $79.9 million, up 53.95% from the prior year.
• Interest & Investment Income for Q1 2012 stood at $26.1 million, up from $24.4 million in the prior quarter.
• The five-year high for Interest & Investment Income was $718.7 million in Q3 2009, with the low at $10.6 million in Q1 2010.
• Historically, Interest & Investment Income has averaged $81.4 million across 4 years, with a median of $17.8 million in 2011.
• Annual changes were most pronounced in 2010 — Interest & Investment Income sank 97.73% — and 2011, when it soared 74.29%.
• Eli Lilly's Interest & Investment Income stood at $718.7 million in 2009, then sank by 98.05% to $14.0 million in 2010, then soared by 74.29% to $24.4 million in 2011, then advanced by 6.97% to $26.1 million in 2012.
• The last three Interest & Investment Income figures came in at $26.1 million (Q1 2012), $24.4 million (Q4 2011), and $22.2 million (Q3 2011), per Business Quant data.